Get started
Keyword

PSA screening

Description: PSA screening is testing asymptomatic people for prostate-specific antigen in blood to assess their risk of prostate cancer.
OpenAlex ID: keywords/psa-screening
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 · Virginia A. Moyer, on behalf of the U.S. Preventive Services Task Force* · Annals of Internal Medicine · 2,524
Radical Prostatectomy versus Observation for Localized Prostate Cancer
2012 · Timothy J. Wilt, Michael K. Brawer, et al. · New England Journal of Medicine · 1,770
PDF
Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends
2002 · R. Etzioni · JNCI Journal of the National Cancer Institute · 949
Prostate cancer
2015 · Gerhardt Attard, Chris Parker, et al. · The Lancet · 940
Prostate-specific antigen and prostate cancer: prediction, detection and monitoring
2008 · Hans Lilja, David Ulmert, et al. · Nature reviews. Cancer · 921
Prostate Cancer
2010 · James Mohler, Robert R. Bahnson, et al. · Journal of the National Comprehensive Cancer Network · 897
PDF
Multiple newly identified loci associated with prostate cancer susceptibility
2008 · The UK Genetic Prostate Cancer Study Collaborators, Rosalind A Eeles, et al. · Nature Genetics · 844
The Epidemiology of Prostate Cancer
2018 · Claire H. Pernar, Ericka M. Ebot, et al. · Cold Spring Harbor Perspectives in Medicine · 802
PDF
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
2009 · G. Draisma, R. Etzioni, et al. · JNCI Journal of the National Cancer Institute · 796
PDF
Progress in cancer screening practices in the United States
2003 · Judith Swan, Nancy Breen, et al. · Cancer · 767
Systematic 5 Region Prostate Biopsy is Superior to Sextant Method for Diagnosing Carcinoma of the Prostate
1997 · L. Andrew Eskew, Ricky L. Bare, et al. · The Journal of Urology · 745
Biology of Prostate-Specific Antigen
2003 · Steven P. Balk, Yoo-Joung Ko, et al. · Journal of Clinical Oncology · 729
Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019
2022 · Le Wang, Bin Lu, et al. · Frontiers in Public Health · 648
PDF
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis
2018 · Dragan Ilic, Mia Djulbegovic, et al. · BMJ · 644
PDF
Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005
2009 · H. G. Welch, P. C. Albertsen · JNCI Journal of the National Cancer Institute · 575
PDF
Health Behaviors of Cancer Survivors: Examining Opportunities for Cancer Control Intervention
2005 · Keith M. Bellizzi, Julia H. Rowland, et al. · Journal of Clinical Oncology · 561
PDF
Epidemiology of prostate cancer
2003 · E.David Crawford · Urology · 549
Risk factors for prostate cancer incidence and progression in the health professionals follow‐up study
2007 · Edward Giovannucci, Yan Liu, et al. · International Journal of Cancer · 522
PDF
Prevention and early detection of prostate cancer
2014 · Jack Cuzick, Mangesh A Thorat, et al. · The Lancet Oncology · 496
PDF
A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer
2006 · Jocelyn S. Kasper, Edward Giovannucci · Cancer Epidemiology Biomarkers & Prevention · 491
PDF
Quality-of-Life Effects of Prostate-Specific Antigen Screening
2012 · Eveline A.M. Heijnsdijk, Elisabeth M. Wever, et al. · New England Journal of Medicine · 427
PDF
Quantifying the role of PSA screening in the US prostate cancer mortality decline
2007 · Ruth Etzioni, Alex Tsodikov, et al. · Cancer Causes & Control · 423
Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era
2009 · Andrew J. Stephenson, Michael W. Kattan, et al. · Journal of Clinical Oncology · 421
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
2008 · Jing Ma, Haojie Li, et al. · The Lancet Oncology · 421
PDF
Statin Drugs and Risk of Advanced Prostate Cancer
2006 · Elizabeth A. Platz, Michael F. Leitzmann, et al. · JNCI Journal of the National Cancer Institute · 407
PDF
Works count: 5,777
Citation count: 83,860
Year
Topic
Type